COMPARISON OF MISOPROSTOL WITH OXYTOCIN IN THIRD STAGE OF LABOUR

Authors

  • Nilam Subedi Department of Obstetrics & Gynaecology,Universal College ofMedical Sciences, Bhairahawa
  • Deepanjali Sharma Department of Obstetrics & Gynaecology,Universal College ofMedical Sciences, Bhairahawa
  • Rubby Das Department of Obstetrics & Gynaecology,Universal College ofMedical Sciences, Bhairahawa

DOI:

https://doi.org/10.3126/jucms.v6i1.21694

Keywords:

Third Stage ofLabour, Postpartum Haemorrhage, Misoprostol, Oxytocin

Abstract

Introduction: Postpartum Haemorrhage (PPH) is one of the leading causes of maternal mortality worldwide. A simple measure to prevent PPH is active management of third stage of labour (AMTSL). This prospective study was conducted in Universal College of Medical Sciences and Teaching Hospital, Tribhuvan University,  Bhairahawa where misoprostol  600  mcg  orally was compared with the standard  oxytocin regime in active management of third stage of labour.

Materials and Methods: A total of 100 women were selected to receive either 600 mcg misoprostol orally or 10 IU oxytocin intramuscularly. The incidences of postpartum hemorrhage and side effects were examined.

Results: Both groups were comparable in age, parity, gestational age, pre-delivery hemoglobin, and duration of labor. There was no significant differences between the misoprostol and oxytocin groups in terms of blood loss  96% vs 100% had blood loss of < 500 ml, p=0.475). And incidence of PPH  (4% vs 0%). None of the group had severe PPH i.e. blood loss> 1000 ml. The duration of the third stage of labor, a secondary outcome measure was shorter in the misoprostol group than in the oxytocin group (7.02±2.26 SD vs 8.44±4.08 SD, p=0.034). Two women of oxytocin group received a blood transfusion. The adverse effects of shivering and pyrexia were encountered more frequently in the misoprostol than in the oxytocin group (2% vs 38%, p<0.001, P<0.001; and 2% vs 10%, p=0.207). No major surgical intervention for atonic PPH was needed and no maternal deaths occurred in either group.

Conclusion: Misoprostol 600 mcg orally is equally as effective as standard oxytocin regime in AMTSL to prevent PPH and can be safely used in the peripheral institutions or by midwives where there is lack of trained personnel and storage facility.

Journal of Universal College of Medical Sciences

Vol. 6, No. 1, 2018, Page: 19-21

Downloads

Download data is not yet available.
Abstract
603
PDF
539

Author Biographies

Nilam Subedi, Department of Obstetrics & Gynaecology,Universal College ofMedical Sciences, Bhairahawa

Lecturer

Deepanjali Sharma, Department of Obstetrics & Gynaecology,Universal College ofMedical Sciences, Bhairahawa

Lecturer

Rubby Das, Department of Obstetrics & Gynaecology,Universal College ofMedical Sciences, Bhairahawa

Resident

Downloads

Published

2018-11-20

How to Cite

Subedi, N., Sharma, D., & Das, R. (2018). COMPARISON OF MISOPROSTOL WITH OXYTOCIN IN THIRD STAGE OF LABOUR. Journal of Universal College of Medical Sciences, 6(1), 19–21. https://doi.org/10.3126/jucms.v6i1.21694

Issue

Vol. 6 No. 1 (2018)

Section

Original Articles

License

Authors have to give the following undertakings along with their article:

  1. I/we declare that this article is original and has not been submitted to another journal for publication.
  2. I/we declare that I/we surrender all the rights to the editor of the journal and if published will be the property of the journal and we will not publish it anywhere else, in full or part, without the permission of the Chief Editor.
  3. Institutional ethical and research committee clearance certificate from the institution where work/research was done, is required to be submitted.
  4. Articles in the Journal are Open Access articles published under the Creative Commons CC BY-NC License (https://creativecommons.org/licenses/by-nc/4.0/)
  5. This license permits use, distribution and reproduction in any medium, provided the original work is properly cited, and it is not used for commercial purposes.